Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal sufentanil + bupivacaine versus dexmedetomidine + bupivacaine in cesarean delivery
IRCT201307236625N2Phase 2Completed
- Sponsor
- Research Deputy of Babol University of Medical Sciences
- Start
- Feb 2013
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of sufentanil, dexmedetomidine and bupivacaine in anesthesia complication (2 arms), sponsored by Research Deputy of Babol University of Medical Sciences. Primary endpoint: Duration of analgesia. Started Feb 2013; status: completed.
02
Drugs
sufentanildexmedetomidinebupivacaine
03
Conditions
anesthesia complication
Beyond the preview
Go deeper on IRCT201307236625N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201307236625N2.